Brief: Protara Therapeutics Announces Second Quarter 2023 Financial Results And Business Update
03/08/2023 14:51
Protara Therapeutics Inc TARA.O :
* PROTARA THERAPEUTICS ANNOUNCES SECOND QUARTER 2023
FINANCIAL
RESULTS AND BUSINESS UPDATE
* PROTARA THERAPEUTICS INC Q2 LOSS PER SHARE $1.00
* PROTARA THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS OF $80M AS OF JUNE 30, 2023 EXPECTED TO FUND
OPERATIONS INTO 2025
* PROTARA THERAPEUTICS INC - COMPANY PLANS TO INITIATE PHASE
2
TRIAL OF TARA-002 IN LYMPHATIC MALFORMATIONS IN 4Q23
Source text for Eikon: ID:nGNX3rl4Vf
Further company coverage: TARA.O
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses